Xilio Therapeutics, Inc.XLONASDAQ
Loading
Cash & Equivalents Over TimeExpanding
Percentile Rank83
3Y CAGR+4.5%
5Y CAGR+48.2%
Year-over-Year Change
Cash on hand plus short-term liquid investments
3Y CAGR
+4.5%/yr
Annual compound
5Y CAGR
+48.2%/yr
Recent deceleration
Percentile
P83
Within normal range
vs 5Y Ago
7.1x
Strong expansion
Streak
2 yr
Consecutive growthExpanding
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $137.53M | +148.7% |
| 2024 | $55.29M | +23.7% |
| 2023 | $44.70M | -62.9% |
| 2022 | $120.39M | -39.2% |
| 2021 | $198.05M | +929.5% |
| 2020 | $19.24M | -60.6% |
| 2019 | $48.84M | - |